Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan

Citterio, L; Bianchi, G; Scioli, GA; Glorioso, N; Bigazzi, R; Cusi, D; Staessen, JA; Cavuto, S; Ferrandi, M; Lanzani, C; Li, XY; Lau, LF; Chiang, CE; Wang, TD; Wang, KL; Ferrari, P; Manunta, P

Bianchi, G (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.

PHARMACOGENOMICS JOURNAL, ; ():

Abstract

We compared a standard antihypertensive losartan treatment with a pharmacogenomics-guided rostafuroxin treatment in never-treated Caucasian and Chines......

Full Text Link